AI assistant
TP ICAP Group PLC Major Shareholding Notification 2021
5209_mrq_2021-10-26_b3ba5f1c-96f0-4537-b641-3a9d5ec35559.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 3154Q
TP Group PLC
26 October 2021
TP Group plc
("TPG" or "the Company")
Response re. Science Group Announcement
Further to the announcement made by Science Group plc ("SG") on 26 October 2021, the Company confirms that it yesterday received a letter from SG, a substantial shareholder in TPG, requisitioning a general meeting, seeking to implement changes to the Company's board.
The letter seeks for the following ordinary resolutions to be tabled at a general meeting:
· That Mr Philip Holland be removed from office as a director of the Company with immediate effect.
· That any director of the Company appointed between 21 October 2021 and the date of shareholder general meeting be removed as a director with immediate effect.
A further announcement will be made in due course in connection with the notice of the general meeting which, pursuant to the Companies Act, must be called within 21 days following receipt of the letter.
For further information, please contact:
| TP Group plc | Tel: 01753 285 810 |
| David Lindsay, Chief Executive Officer | |
| Derren Stroud, Chief Financial Officer | |
| www.tpgroup.uk.com | |
| Cenkos Securities plc | Tel: 020 7397 8980 |
| Stephen Keys / Mark Connelly / Callum Davidson | |
| www.cenkos.com | |
Notes to Editors
TP Group delivers complex equipment, software and services for mission-, business- and safety-critical applications in defence, space, intelligence & security and energy sectors. With more than 400 people in 6 European countries, it serves global customers through long-term contracts. The Company's shares have been traded on AIM since July 2001.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FURDKABDBBDDBKB